Effects of Open-label vs Double-blind Treatment in IBS

NCT02802241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2024-01-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.

Conditions

  • Irritable Bowel Syndrome
  • Placebo Effect
  • Placebos
  • Peppermint Oil

Interventions

DRUG

placebo

DIETARY_SUPPLEMENT

peppermint oil

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02802241 on ClinicalTrials.gov